Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

12 févr. 2021 07h30 HE | Source: Progenity, Inc.

SMFM Conference and Publications Highlight the Challenges and Complexities of Diagnosing and Managing Preeclampsia

SAN DIEGO, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
23 janv. 2017 15h08 HE | Source: Sera Prognostics, Inc.

Research on Underlying Mechanisms of Pregnancy Complications and Medical Interventions Using Sera’s Proteomic Technology to be Presented at the Society for Maternal-Fetal Medicine’s 37th Annual Pregnancy Meeting

SALT LAKE CITY, Jan. 23, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced the presentation of ongoing research evaluating the underlying mechanisms of...
04 févr. 2016 15h15 HE | Source: Sera Prognostics, Inc.

Positive Clinical Validation Data for PreTRM® Test Presented at the Society for Maternal-Fetal Medicine’s 36th Annual Pregnancy Meeting

SALT LAKE CITY, Feb. 04, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that results from the 5,501-patient Proteomic Assessment of Preterm Risk...